EXPERIENCED CRO/CDMO

Zelmic is a contract research and development organization initially founded in 2002. It has developed several topical drugs and patented technologies for its customers. 

The company offers services in topical formulation development for small molecules, peptides, and proteins. The analytical capacity is R&D, GMP analysis, validation, and stability studies according to ICH can be performed. Zelmic can perform in vitro performance testing with in-vitro release testing (IVRT), In-vitro permeation testing (IVPT) with skin, nail, and mucous membranes according to draft EMA guidance. In 2022 Zelmic extended the service to include GMP manufacture of non-sterile products.